Why the study?
Does the inactivated polio vaccine provide long-term sero-immunity against poliomyelitis in the Swedish population?
Population
Swedish population (over 99% of those born in the 1940s and later, and at least 90% of those born earlier)
Design
Cross-sectional
Follow-up
25 years
Authors
Loading...
Supports durable IPV sero-immunity in Swedish adults; leaves open generalizability and requires prospective confirmation before wider adoption.
Does the inactivated polio vaccine provide long-term sero-immunity against poliomyelitis in the Swedish population?
General vaccination with inactivated polio vaccine provides stable, long-term sero-immunity in the Swedish population up to 25 years post-vaccination.
M Böttiger (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: